Evidence map›Paper›PMID 10189371›Full record

ArticleThe Journal of cell biology1999

Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis.

J Zhang, M C Reedy, Y A Hannun, L M Obeid

Abstract read
In one paragraph

Article in The Journal of cell biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Brain Ultrastructure: Putting the Pieces Together.Frontiers in cell and developmental biology · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Label-free Raman observation of cytochrome c dynamics during apoptosis.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  16. Article
  17. Article
  18. Measurement of cell death in mammalian cells.Current protocols in pharmacology · 2004
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J ZhangVeterans Administration Geriatrics Research Education and Clinical Center and the Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.
M C Reedy
Y A Hannun
L M Obeid

Funding

Sphingomyelin Turnover and Cellular RegulationR37GM043825 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI HANNUN, YUSUF AWNI · 2007 to 2015
$3.7M
Mitochondrial Ceramide in Chemotherapy-induced ApoptosisR01AG016583 · NIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OBEID, LINA M · 1998 to 2010
$2.7M
SPHINGOMYELIN TURNOVER AND CELLULAR REGULATIONR01GM043825 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HANNUN, YUSUF AWNI · 1991 to 2006
$2.2M
NIA NIH HHS R01 AG016583NIA NIH HHS R01 AG16583-01NIGMS NIH HHS GM 43825NIGMS NIH HHS R01 GM043825NIGMS NIH HHS R37 GM043825
6 · The paper itself

Abstract

During apoptosis, the cell actively dismantles itself and reduces cell size by the formation and pinching off of portions of cytoplasm and nucleus as "apoptotic bodies." We have combined our previously established quantitative assay relating the amount of release of [3H]-membrane lipid to the degree of apoptosis with electron microscopy (EM) at a series of timepoints to study apoptosis of lymphoid cells exposed to vincristine or etoposide. We find that the [3H]-membrane lipid release assay correlates well with EM studies showing the formation and release of apoptotic bodies and cell death, and both processes are regulated in parallel by inducers or inhibitors of apoptosis. Overexpression of Bcl-2 or inhibition of caspases by DEVD inhibited equally well the activation of caspases as indicated by PARP cleavage. They also inhibited [3H]-membrane lipid release and release of apoptotic bodies. EM showed that cells overexpressing Bcl-2 displayed near-normal morphology and viability in response to vincristine or etoposide. In contrast, DEVD did not prevent cell death. Although DEVD inhibited the chromatin condensation, PARP cleavage, release of apoptotic bodies, and release of labeled lipid, DEVD-treated cells showed accumulation of heterogeneous vesicles trapped in the condensed cytoplasm. These results suggest that inhibition of caspases arrested the maturation and release of apoptotic bodies. Our results also imply that Bcl-2 regulates processes in addition to caspase activation.

Indexed as

Caspase InhibitorsAntineoplastic Agents, PhytogenicApoptosisCaspase 1Caspase 3Cell SizeChromatinCysteine Proteinase InhibitorsEtoposideLeukemia, T-CellMembrane LipidsMicroscopy, ElectronNeoplasm ProteinsOligopeptidesPoly(ADP-ribose) PolymerasesPrecursor B-Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Agents, Phytogenicbenzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketoneCaspase 1Caspase 3Caspase InhibitorsChromatinCysteine Proteinase InhibitorsEtoposideMembrane LipidsNeoplasm ProteinsOligopeptidesPoly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-bcl-2Recombinant Fusion Proteinstyrosyl-valyl-alanyl-aspartal

Identifiers

PMID10189371
PMCPMC2148221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.